– USA, NJ – MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, today announced that Michael J. Hennessy Jr., who has been serving as company president since 2015, takes the helm of daily operations in the dual role of president and CEO effective immediately.
Hennessy Sr. will continue in his current role as company chairman, focusing on strategic growth and serving as an adviser to the executive team.
As president, Hennessy Jr. oversaw a multiyear growth spurt for MJH that vaulted the company to market-leading positions in media, education and research. His leadership and precision in delivering a quality content platform that health professional audiences find reliable was instrumental in the company’s growth. By ensuring success in audience engagement and revenue generation with media platforms, such as OncLive, Targeted Oncology, CURE, Pharmacy Times, The American Journal of Managed Care, medical education standouts PER and PTCE, and research solutions with HRA Hennessy Jr. placed the company in a position to make the major acquisition of UBM Life Sciences earlier this year. The new CEO has reinvigorated interest and investment in over 40 traditional legacy medical media assets including Medical Economics, Psychiatric Times, Ophthalmology Times, Cancer Network, Dermatology Times, Pharmaceutical Executive, BioPharm International, Applied Clinical Trials, as well as retooling the dvm360 veterinarian unit and Dental Products Report properties.
In transitioning the CEO reins, MJH Life Sciences Chairman and Founder Michael J. Hennessy Sr., expressed his full confidence in Hennessy Jr.’s ability to steer the company forward.
“Mike has achieved tremendous success in the past several years as president, proving himself a strong strategic thinker but also demonstrating his ability to develop a team of successful managers to drive revenue and to execute on the delivery side,” Hennessy Sr. said. “Backed with my unwavering support and an experienced corporate management team, I know that Mike will continue to advance our company to new heights. We have a nice mix of youth and experience under Mike that will continue to fuel our business.”
In moving into his new role, Hennessy Jr. said, “With the success of our recent corporate growth, it is an incredibly exciting time at MJH Life Sciences™. I could not be more grateful for the opportunity to continue cultivating our core strength as a content leader and working to deliver trusted and relevant information to health professionals. I look forward to shaping the future of our company and the health care communications industry as a whole.”
About MJH Life Sciences
MJH is the largest privately held, independent, a full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies.
For more information: https://www.mjhlifesciences.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
